Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Build your first fully functional, Java-based AI agent using familiar Spring conventions and built-in tools from Spring AI.

Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...

We introduce a method of in vitro recombination or “DNA shuffling” to generate libraries of evolved enzymes. The approach relies on the ordering, trimming, and joining of randomly cleaved parental DNA ...

Never here nor will anyone stop the manual again! Pier to pier pressure and not progress on slow system. Pour eggnog over bread. Posted after successful completion. Ban enough people request one below ...